Cargando…
COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF)
There are two key needs in COVID-19 management: (i) to reduce SARS-CoV-2 viral infection rate; and (ii) to reduce death rate of those infected - the subject of this commentary. The current WHO estimated global mortality rate is 3.4% (March 2020) and the global death toll has now past 200,000 (April...
Autor principal: | Metcalfe, Su M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227543/ http://dx.doi.org/10.1016/j.medidd.2020.100043 |
Ejemplares similares
-
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
por: Rittchen, Sonja, et al.
Publicado: (2015) -
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
por: Metcalfe, Su M
Publicado: (2020) -
CD133(+ )adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF)
por: Carter, Debra A, et al.
Publicado: (2009) -
Leukaemia Inhibitory Factor (LIF) Inhibits Cancer Stem Cells Tumorigenic Properties through Hippo Kinases Activation in Gastric Cancer
por: Seeneevassen, Lornella, et al.
Publicado: (2020) -
Retinal blood vessel‐origin yes‐associated protein (YAP) governs astrocytic maturation via leukaemia inhibitory factor (LIF)
por: Ai, Li‐Qian‐Yu, et al.
Publicado: (2020)